A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Type 2 diabetes patients ... various diabetes medications. The study methodology involved comparing SGLT-2 inhibitor users with those taking DPP-4 inhibitors, another common diabetes medication ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
affecting more than 60% of people with Type 2 diabetes. Other common deficiencies included magnesium (42%), iron (28%) and vitamin B12 (22%). People on the diabetes drug metformin were at higher ...
Researchers estimate that about 828 million adults around the world live with diabetes, with 90% of them having type 2 diabetes ... researchers focused on the SGLT-2 drug dapagliflozin, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback